FENRIN™

Therapeutic Segment:
Diuretic

Generic Name:
Finerenone

Description:
FENRIN contains finerenone, a nonsteroidal mineralocorticoid receptor antagonist.

Indication:
Finerenone is indicated to reduce the risk of sustained eGFR decline, end-stage kidney disease, cardiovascular death, non-fatal myocardial (Finerenone) 10mg & 20mg Tablets infarction, and hospitalization for heart failure in adult patients with chronic kidney disease (CKD) associated with type 2 diabetes (T2D).

Formulation:

• Tablets

Strength:

• 10mg
• 20mg

Pack Size:

• 14’s
• 14’s